Ушбу ишга иқтибос қилган ишлар

2 та иш

Иш: Statins and PCSK9 inhibitors: What is their role in coronavirus disease 2019?

1. Analysis of influence of background therapy for comorbidities in the period before infection on the risk of the lethal COVID outcome. Data from the international ACTIV SARS-CoV-2 registry («Analysis of chronic non-infectious diseases dynamics after COVID-19 infection in adult patients SARS-CoV-2»)

   E. I. Tarlovskaya, A. G. Arutyunov, А. О. Конради +97

   МақолаLong-Term Effects of COVID-19Kardiologiia20210 иқтибос

   ABIABI:AkademIndex/openalex/2021.article.000346

2. Nanoparticle-Based PCSK9 Inhibition in Viral Infections: Evaluating Clinical Limitations and Advancing Therapeutic Strategies

   Moeen F. Dababneh, Bahjat Alhasso, Abdulkareem Shareef +10

   МақолаLipoproteins and Cardiovascular HealthJournal of Pharmaceutical Innovation20260 иқтибос

   ABIABI:AkademIndex/openalex/2026.article.013240